CORRADINI, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.969
EU - Europa 7.387
AS - Asia 5.405
SA - Sud America 788
AF - Africa 127
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 3
Totale 23.717
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.778
SE - Svezia 2.236
IT - Italia 1.696
SG - Singapore 1.580
CN - Cina 1.522
GB - Regno Unito 1.293
BR - Brasile 603
DE - Germania 602
VN - Vietnam 595
HK - Hong Kong 539
FI - Finlandia 437
BD - Bangladesh 248
KR - Corea 245
FR - Francia 222
RU - Federazione Russa 194
UA - Ucraina 184
TR - Turchia 134
NL - Olanda 132
IN - India 121
CA - Canada 100
ID - Indonesia 91
AR - Argentina 74
BG - Bulgaria 62
MX - Messico 59
JP - Giappone 55
PL - Polonia 43
IQ - Iraq 40
LT - Lituania 39
IE - Irlanda 36
AU - Australia 34
BE - Belgio 34
PK - Pakistan 33
ZA - Sudafrica 31
AT - Austria 30
RO - Romania 27
AE - Emirati Arabi Uniti 26
ES - Italia 26
MA - Marocco 23
CL - Cile 22
CH - Svizzera 21
EC - Ecuador 21
MY - Malesia 19
UZ - Uzbekistan 19
VE - Venezuela 18
CO - Colombia 17
IL - Israele 16
SA - Arabia Saudita 15
DZ - Algeria 14
EG - Egitto 12
AZ - Azerbaigian 11
PY - Paraguay 11
TN - Tunisia 11
JO - Giordania 10
TW - Taiwan 10
KE - Kenya 9
KZ - Kazakistan 9
PT - Portogallo 9
BO - Bolivia 8
CR - Costa Rica 8
IR - Iran 8
NP - Nepal 8
OM - Oman 7
PH - Filippine 7
UY - Uruguay 7
AL - Albania 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
PE - Perù 6
RS - Serbia 6
BY - Bielorussia 5
DK - Danimarca 5
HU - Ungheria 5
LB - Libano 5
LU - Lussemburgo 5
SI - Slovenia 5
TH - Thailandia 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
KG - Kirghizistan 4
KH - Cambogia 4
KW - Kuwait 4
SY - Repubblica araba siriana 4
AO - Angola 3
HR - Croazia 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CD - Congo 2
CI - Costa d'Avorio 2
CY - Cipro 2
GA - Gabon 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
Totale 23.687
Salva come PNG Salva come JPEG
Città #
Stockholm 1.794
Santa Clara 1.016
Singapore 1.003
Ashburn 978
Fairfield 869
Southend 821
Hefei 543
Hong Kong 532
San Jose 496
Woodbridge 489
Chandler 485
Houston 413
Helsinki 368
London 318
Seattle 293
Cambridge 277
Council Bluffs 269
Jacksonville 260
Wilmington 256
Nyköping 255
Dallas 252
Beijing 246
Chicago 236
Seoul 231
Modena 212
Ann Arbor 209
Berlin 208
Dearborn 208
Ho Chi Minh City 200
Los Angeles 194
Hanoi 146
Milan 136
New York 135
The Dalles 124
San Diego 102
Bologna 96
Princeton 69
Rome 67
Lauterbourg 65
Munich 61
Sofia 61
Moscow 60
Frankfurt am Main 58
São Paulo 58
Shanghai 57
Jakarta 56
Izmir 54
Buffalo 52
Orem 51
Eugene 50
Parma 48
Redwood City 43
Salt Lake City 43
Amsterdam 36
Bremen 36
Phoenix 35
Tokyo 33
Yalova 33
Warsaw 32
Toronto 31
Dublin 28
Atlanta 27
Brussels 27
Reggio Emilia 27
Elk Grove Village 26
Nuremberg 26
Da Nang 24
Des Moines 24
Redondo Beach 24
Brooklyn 23
Florence 23
Haiphong 23
Kent 23
Chennai 22
Mexico City 22
Boardman 21
Bari 20
San Francisco 20
Tampa 20
Montreal 19
Paris 19
Rio de Janeiro 19
Borzano 18
Hải Dương 17
Turin 17
Turku 17
Baghdad 16
Formigine 16
Hemrik 16
Nanjing 16
Naples 16
Rimini 16
Vienna 16
Brisbane 15
Guangzhou 15
Lappeenranta 15
Columbus 14
Denver 14
Dong Ket 14
Johannesburg 13
Totale 16.647
Salva come PNG Salva come JPEG
Nome #
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.828
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 484
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 475
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 423
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 421
Non-HFE Hepatic Iron Overload. 419
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. 412
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 409
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 402
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 399
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 374
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 356
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 355
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 355
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 349
Subacute copper-deficiency myelopathy in a patient with occult celiac disease 346
Iron Regulation of Hepcidin Despite Attenuated Smad1,5,8 Signaling in Mice Without Transferrin Receptor 2 or Hfe. 343
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 337
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 336
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 328
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 327
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 327
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 322
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 318
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 304
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 304
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 300
Iron and steatohepatitis. 299
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 292
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 291
Disease progression and liver cancer in the ferroportin disease 285
Lack of enterocyte iron accumulation in the ferroportin disease 280
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 270
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 268
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 264
Can Disruption of Basal Ganglia-Thalamocortical Circuit in Wilson Disease Be Associated with Juvenile Myoclonic Epilepsy Phenotype? 262
GLUCONEOGENIC SIGNALS DIRECTLY CONTROL IRON HOMEOSTASIS THROUGH HEPCIDIN 259
Capitolo 8 "Epatopatie da accumulo: malattia di Wilson ed emocromatosi", in Sezione I "Epatiti acute e croniche" 259
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 258
Fifty meanings of grey 254
A Pair of Brothers with Aceruloplasminemia Due To A Novel Nonsense Mutation: Unusual Phenotype And Neurological Improvement After Iron-Chelation Therapy With Deferasirox 249
The RGM/DRAGON family of BMP co-receptors. 247
EASL Clinical Practice Guidelines on haemochromatosis 237
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease 236
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin 231
Hereditary hemochromatosis. 231
Molecular and clinical correlates in iron overload associated with mutations in ferroportin 230
Hereditary Hemochromatosis 224
A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages 223
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 223
CREB-H is a stress-regulator of hepcidin gene expression during early postnatal development 221
SEX HORMONES DIFFERENTLY REGULATE HEPCIDIN EXPRESSION AND IRON HOMEOSTASIS IN VIVO. 220
Genetic iron overload disorders 215
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 212
Iron Metabolism in the Disorders of Heme Biosynthesis 209
Idiopathic brain calcification in a patient with hereditary hemochromatosis 201
Hyperferritinemia and diagnosis of type 1 Gaucher disease 201
Post COVID-19 irritable bowel syndrome 200
Fortune favours the bold: finding the right route in the anemia's sea 196
Impact of natural neuromedin-B receptor variants on iron metabolism 192
Labile plasma iron and echocardiographic parameters are associated to cardiac events in beta-thalassemic patients 191
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 189
null 186
Hereditary Haemochromatosis: the genes and the disease. 185
Metodologia per l’adozione di linee guida cliniche in Medicina Interna. 181
Assistenza sanitaria primaria. Vol. 2: La formazione medica per il suo sviluppo 172
A Population-based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia 170
Iron and the liver 168
STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo 167
Use of digital technologies to support cancer screening in community health promotion interventions: scoping review 167
Iron in Porphyrias: Friend or Foe? 162
Juvenile hemocromatosis associated with pathogenetic mutations of adult hemocromatosis genes 160
Consensus Statement on the definition and classification of metabolic hyperferritinaemia 157
Fegato, pancreas e vie biliari. 157
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia (Nature Reviews Endocrinology, (2023), 19, 5, (299-310), 10.1038/s41574-023-00807-6) 150
Haemochromatosis 146
Assistenza sanitaria primaria. Aspetti culturali, metodi e strumenti per il suo sviluppo 144
Corrigendum to “EASL Clinical Practice Guidelines on haemochromatosis” [J Hepatol 2022 (77) 479–502](S0168827822002112)(10.1016/j.jhep.2022.03.033) 139
Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort 136
Developing an integrated care pathway to connect home-based palliative care and emergency departments: participatory action research on a quality improvement project 131
Role and challenges to digital technologies in community health promotion programs in Italy during the COVID-19 pandemic: a multiple embedded case study protocol 129
Erratum: Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene (Blood Cells, Molecules, and Diseases (2003) 31 (299-304) DOI: 10.1016/S1079-9796(03)00164-5) 129
Iron overload disorders 128
Hypoparathyroidism in adults with iron overload diseases (IOD): evidence of a subclinical phenotype 118
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group 114
Haematological parameters in erythropoietic protoporphyria: A multi-national study 112
Reply to: “Ceruloplasmin variants might have different effects in different iron overload disorders” 107
Prevalence of malnutrition and its impact on clinical outcomes in internal medicine wards: The SIMI-NUTRO study 99
SEX HORMONES DIFFERENTLY REGULATE HEPATIC HEPCIDIN EXPRESSION AND SYSTEMIC IRON HOMEOSTASIS IN VIVO 86
Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome 85
Genome-wide association for sarcoidosis identifies novel risk loci and genetic heritability in African and European ancestries: a meta-analysis from the Finngen, Million Veteran Program, UK Biobank, and Biobank Japan datasets. 67
Characterization of ferroportin disease and SLC40A1-related hemochromatosis – Results from the EASL non-HFE registry 66
Porphyrias: Pathophysiology and clinical management recommendations for hepatologists 55
Lipidic nanomedicines enhance Hinokitiol activity on human primary macrophages from Ferroportin disease patients 43
Totale 23.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.934
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021181 0 0 0 0 0 0 0 0 0 0 0 181
2021/20221.503 90 127 179 58 82 65 111 104 196 107 216 168
2022/20231.571 153 165 110 137 197 208 44 177 186 39 90 65
2023/20241.179 59 68 128 118 152 83 96 159 35 83 101 97
2024/20254.019 165 48 100 255 757 593 222 223 459 193 501 503
2025/202610.521 560 426 816 817 883 677 1.051 485 2.833 995 594 384
Totale 23.888